Skip to main content

Table 1 Demographic and clinical characteristics.

From: Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial

Characteristics

MG

(n = 37)

CG

(n = 31)

P

value

 

Males, number (%)

27 (72)

26 (83)

0.28

 

Age

43 ± 18

45 ± 17

0.60

 

Weight

82 ± 16

84 ± 19

0.58

 

APACHE II

19 ± 8

18 ± 6

0.59

 

Cause of hospitalization, n (%)

    

   Trauma

17 (45)

14 (45)

0.94

 

   Respiratory

6 (16)

3 (9)

0.42

 

   Sepsis

5 (13)

7 (22)

0.32

 

   Abdominal surgery

5 (13)

2 (6)

0.33

 

   Neurological

3 (8)

3 (9)

0.82

 

   Exogenous intoxication

0

2 (6)

0.11

 

   Cardiac

1 (2)

0

0.35

 

Fentanyl Initial dose (μg/kg/h)

2.15 ± 1.06

2.35 ± 1.21

0.48

 

   Accumulated dose (μg)

40,608 ± 24,882

41,284 ± 20,545

0.90

 

Midazolam maleate

    

   Accumulated dose (mg)

1,052 ± 820

1,014 ± 672

0.83

 

Days on fentanyl before start of weaning

10.1 ± 6

10.4 ± 4.4

0.80

 

MV days before start of weaning

10.6 ± 6.8

10.3 ± 4.5

0.87

 

ΔT Hosp. X ICU

3 ± 8

4 ± 12

0.88

 
  1. Data are presented as n (%) or mean ± standard deviation. ΔT Hosp. X ICU = Time from hospital stay until ICU admission. APACHE, acute physiology and chronic health evaluation; CG, Control group; ICU, intensive care unit; MG, methadone group; MV, mechanical ventilation